Written and maintained by CASRAI Editorial Board
Last updated
The disability-adjusted life year (DALY) is a standardized metric designed to quantify overall disease burden by combining mortality and non-fatal health loss into a single unit.
Short answer
A Disability-Adjusted Life Year (DALY) is a standardized composite metric that quantifies total disease burden as the loss of the equivalent of one full year of healthy life. One DALY equals one lost healthy year, calculated as premature mortality (Years of Life Lost, YLL) plus non-fatal disability (Years Lived with Disability, YLD).
Definition and scope
The disability-adjusted life year was developed in the early 1990s by Christopher Murray and Alan Lopez in collaboration with the World Health Organization (WHO) and the World Bank for the 1993 World Development Report. Today, it serves as the core metric for the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD), coordinated by the Institute for Health Metrics and Evaluation (IHME), as well as the WHO Global Health Estimates (GHE).
The purpose of the DALY is to measure the gap between current population health and an ideal scenario where everyone lives into old age free of disease and disability. By converting disparate health consequences into lost years of healthy life, researchers in epidemiology versus public health can compare the burden of premature mortality against chronic disabling conditions across 204 countries and territories.
How it works or how it is used in practice
The DALY framework combines two distinct components: premature mortality and non-fatal morbidity.
DALY = YLL + YLD
Years of Life Lost (YLL)
Years of Life Lost measure fatal health loss due to premature mortality:
YLL = N × L
- N: Number of cause-specific deaths at a given age and sex.
- L: Standard remaining life expectancy at that age, drawn from a theoretical minimum-risk life table (TMRLT) benchmarked to the lowest observed global mortality rates (life expectancy at birth of 86.6 to 88.9 years).
Years Lived with Disability (YLD)
Years Lived with Disability measure non-fatal health impairment. Modern GBD methodology uses a prevalence-based approach:
YLD = P × DW
- P: Number of prevalent cases of a health sequela during the study period.
- DW: Disability weight assigned to that health state.
Earlier WHO studies applied an incidence-based formula (YLD = I × DW × L, where I is incident cases and L is duration). While incidence models remain useful in descriptive and analytical epidemiology, the prevalence-based method aligns directly with population health surveys and life table analysis.
Disability Weights (DW) Calibration
Disability weights are continuous values from 0.0 (full health) to 1.0 (death-equivalent). IHME and WHO derive these weights empirically from multi-country population surveys using paired-comparison questions, where respondents select the healthier of two described health states.
Methodological Evolution
Early GBD studies in the 1990s applied continuous age weights (valuing middle-adult years higher) and a 3% annual time discount rate. Beginning with GBD 2010, both adjustments were removed. Modern DALY accounting is unweighted and undiscounted, treating every year of healthy life equally regardless of age or time horizon.
Worked Example
Suppose a cohort experiences 40 deaths from a cardiovascular condition at age 55. If standard remaining life expectancy at age 55 is 33.5 years, the premature mortality burden is: 40 × 33.5 = 1,340 YLL. If 1,200 individuals also live with associated chronic sequelae for one year with a disability weight of 0.125, the morbidity burden is: 1,200 × 0.125 = 150 YLD. The total burden is: 1,340 YLL + 150 YLD = 1,490 DALYs.
Types or related concepts
DALYs belong to the broader family of health-adjusted life years (HALYs) alongside metrics used in clinical economic evaluations such as the quality-adjusted life year (QALY) and aggregate longevity indicators like healthy life expectancy (HALE).
| Health Metric | Primary Objective | Scale Direction | Scale Range | Weighting Derivation | Primary Institutional Use |
|---|---|---|---|---|---|
| Disability-Adjusted Life Year (DALY) | Quantifies population health loss and disease burden | Minimization (fewer lost healthy years is better) | 0.0 (full health) to 1.0 (death equivalent) | Population paired-comparison surveys of health states | WHO, IHME, GBD Study, global funders, epidemiological prioritization |
| Quality-Adjusted Life Year (QALY) | Quantifies individual health gain and therapeutic utility | Maximization (more quality-adjusted years is better) | 1.0 (perfect health) to 0.0 (death) | Preference elicitation (Time Trade-Off, Standard Gamble, EQ-5D) | Health Technology Assessment (HTA), NICE, PBAC, and health economics research |
| Healthy Life Expectancy (HALE) | Estimates expected years lived in good health | Maximization (longer functional lifespan is better) | Duration in years (bounded by total life expectancy) | Sullivan life tables combining mortality with prevalence YLD | WHO Global Health Observatory and macro public health monitoring |
DALYs and QALYs are not exact opposites. DALY disability weights reflect societal judgments of functional limitation, whereas QALY utility weights reflect individual preferences for health states. Differences in life tables, discounting conventions, and preference weighting methods mean DALY results cannot be directly inverted into QALY thresholds.
Where it matters for labs, clinics or supply decisions
Although computed at the population scale, DALY metrics directly shape healthcare infrastructure, research grants, and diagnostic supply decisions:
- Research Grant Allocations: Global funding bodies, including the Wellcome Trust and the Bill & Melinda Gates Foundation, use DALY rankings to identify neglected diseases where disease burden outpaces current research investment, particularly in tropical medicine and global health.
- Diagnostic Laboratory Planning: In regions where non-communicable conditions dominate DALY totals, health systems invest in automated high-throughput chemistry analyzers for chronic screening. Where infectious diseases drive substantial YLL, procurement focuses on rapid point-of-care serological tests and automated molecular testing platforms.
- Essential Procurement: WHO Essential Medicines and Diagnostics lists use burden data to guide national formularies and clinic stocking tiers, ensuring procurement budgets target the highest causes of premature mortality and disability.
- Acute versus Chronic Care Balancing: Conditions dominated by YLL require capital investment in acute emergency care, resuscitation equipment, and surgical capacity, whereas conditions dominated by YLD require investment in rehabilitation supplies, outpatient monitoring, and long-term pharmaceutical availability.
Common misunderstandings
- Assuming Age Weights and Discounting Still Apply: Many legacy textbooks reference 1990s GBD methods that applied 3% discounting and age-weighting curves. Modern GBD reporting by IHME and WHO has eliminated both adjustments.
- Equating Disability Weights with Human Worth: Disability weights measure the severity of functional health limitation resulting from a condition. They do not assess social value, productivity, or the personal dignity of individuals living with disabilities.
- Treating DALYs as the Direct Inverse of QALYs: Assuming that
1 DALY = 1 − QALYoverlooks differing valuation methods (societal paired comparisons versus individual utility trade-offs) and divergent baseline life tables. - Simple Addition of Comorbid Conditions: Directly summing DALYs across multiple co-occurring conditions can yield impossible disability weights exceeding 1.0. IHME prevents this by applying a multiplicative comorbidity adjustment:
DW_combined = 1 − ∏(1 − DW_i).
FAQ
How do DALYs differ from QALYs in research practice?
DALYs measure disease burden and lost healthy years at the population level, with a goal of minimizing health loss. QALYs measure individual health-related quality of life and intervention benefit, with a goal of maximizing health gains in cost-utility analyses.
What is the difference between YLL and YLD?
Years of Life Lost (YLL) quantify premature death by multiplying mortality counts by standard life expectancy at death. Years Lived with Disability (YLD) quantify non-fatal impairment by multiplying prevalent cases by their assigned disability weight.
Are age weights still used in modern DALY calculations?
No. Standard GBD and WHO methodologies eliminated age weights and time discount rates beginning with GBD 2010, ensuring that every year of healthy life is valued equally across all ages.
Sources
- Institute for Health Metrics and Evaluation (IHME). “Global Burden of Disease (GBD) Study: Concepts and Terms Defined.” Healthdata.org. https://www.healthdata.org/research-analysis/about-gbd. Read November 7, 2026.
- World Health Organization (WHO). “Global Health Estimates (GHE): Life expectancy and leading causes of death and disability.” Who.int. https://www.who.int/data/global-health-estimates. Read November 7, 2026.
- Murray CJL. “Quantifying the burden of disease: the technical basis for disability-adjusted life years.” Bulletin of the World Health Organization 1994; 72(3): 429–445. PMCID: PMC2486718. Read November 7, 2026.
- GBD 2019 Diseases and Injuries Collaborators. “Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019.” The Lancet 2020; 396(10258): 1204–1222. DOI: 10.1016/S0140-6736(20)30925-9. Read November 7, 2026.
